Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 238

recruiting
3 968
countries
28
conditions
2 103

10 282 trials match your criteria

Study on the Use of Ursodeoxycholic Acid for Patients Undergoing Surgery for Retinal Detachment

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ursodeoxycholic Acid

Gastric cancer

Recruiting

Study Comparing Survival in Patients with Advanced or Metastatic Gastric Cancer Treated with Botensilimab and Balstilimab vs. Standard Drug Combination

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Balstilimab

Pruritus

Recruiting

Study on the Effectiveness and Safety of Dupilumab for Adults with Chronic Itch of Unknown Cause

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab

Anal fistula

Recruiting

Study on Treating Perianal Fistulas Using Adipose Derived Regenerative Cells, Metronidazole, and Cefuroxime for Patients with Complex Perianal Fistulas

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Adrc001

Study of Cabozantinib and Durvalumab for Patients with Advanced Bladder Cancer After Chemotherapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib

Major depression+3

Recruiting

Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ketamine

Colorectal cancer+5

Recruiting

Study on Long-Term Safety of Trastuzumab Deruxtecan for Patients with Advanced HER2-Positive or HER2-Mutated Solid Tumors

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anakinra

Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Valaciclovir

Study on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Study on the Effectiveness and Safety of Tinengotinib for Patients with Cholangiocarcinoma Resistant to Chemotherapy and FGFR Inhibitors

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil

Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Crizotinib
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.